The Patent Finder

Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases (2012)

Lakefront Biotherapeutics

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application 61/479,956, filed Apr 28, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,241,931Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
In force
 · High confidence
UsedRemaining
Lakefront BiotherapeuticsIn forceHigh confidence
US 9,987,272Novel Compound Useful for the Treatement of Degenerative and Inflammatory Diseases
In force
 · High confidence
Lakefront BiotherapeuticsIn forceHigh confidence
US 8,802,682Novel Compound Useful for the Treatment of Degenerative and Inflammatory Diseases
In force
 · High confidence
Lakefront BiotherapeuticsIn forceHigh confidence
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited